Source: Υπουργείο Υγείας (CY) Revision Year: 2023 Publisher: Mundipharma Pharmaceuticals Ltd, 13, Othellos str., Dhali Industrial Zone, Nicosia, Cyprus Tel.: +357 22815656 Fax: +357 22487833 Email: info@mundipharma.com.cy
OxyNorm 10 mg/ml solution for injection or infusion.
| Pharmaceutical Form |
|---|
|
Solution for injection or infusion. Clear, colourless solution, practically free from particulates. |
Oxycodone hydrochloride 10 mg/ml (equivalent to 9 mg/ml oxycodone).
For the full list of excipients, see Section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Oxycodone |
Oxycodone is a full opioid agonist with no antagonist properties. It has an affinity for kappa, mu and delta opioid receptors in the brain and spinal cord. Oxycodone is similar to morphine in its action. The therapeutic effect is mainly analgesic, anxiolytic, antitussive and sedative. |
| List of Excipients |
|---|
|
Citric acid monohydrate |
Clear neutral glass ampoules: 1 ml and 2 ml.
Pack size: 5 ampoules.
Mundipharma Pharmaceuticals Ltd, 13, Othellos str., Dhali Industrial Zone, Nicosia, Cyprus
Tel.: +357 22815656
Fax: +357 22487833
Email: info@mundipharma.com.cy
20303
Date of first authorization: 31/3/08
Date of latest renewal: 2/10/2019
| Drug | Countries | |
|---|---|---|
| OXYNORM | Austria, Australia, Brazil, Cyprus, Spain, Finland, France, Hong Kong, Ireland, Netherlands, New Zealand, Poland, Singapore, Tunisia, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
